1.Bibliometric analysis of research hotspots and frontier trends in skin adverse reactions caused by epidermal growth factor receptor inhibitors in the treatment of lung cancer
Kailun HUANG ; Han WANG ; Lingjing ZENG ; Lingna YOU ; Yilan WU
Journal of Shenyang Medical College 2024;26(6):582-588,643
		                        		
		                        			
		                        			Objective:To analyze the research hotspots and frontier trends in skin adverse reactions caused by epidermal growth factor receptor inhibitors(EGFRIs)in the treatment of lung cancer.Methods:CiteSpace software was used to visually analyze the literature on skin adverse reactions caused by EGFRIs in the treatment of lung cancer in the three databases of CNKI,WANFANG and VIP from the establishment of the database to October 30,2023.The literature was analyzed from the aspects of annual publication volume,funding,journals,authors,keywords,etc.Results:A total of 663 Chinese literature were obtained,with national funding projects accounting for 9.20%.A total of 312 journals were involved,with the highest publication volume being the Chinese Journal of Lung Cancer,accounting for 2.71%.The China-Japan Friendship Hospital and the Beijing University of Chinese Medicine were the top two research institutions in terms of the number of published papers,and they had a close cooperation relationship.The top three authors in terms of publication volume were CUI Huijuan with 18 articles,PENG Yanmei with 11 articles,and ZHANG Xu with 9 articles.Research hotspots focus on EGFRIs related rash,gefitinib,and clinical efficacy.Frontier trends focused on the clinical observation,research progress,and traditional Chinese medicine of skin adverse reactions caused by EGFRIs drugs.Conclusions:The research on skin adverse reactions caused by EGFRIs in the treatment of lung cancer has great development prospects.Authors and institutions can further form a stronger collaborative network to promote interdisciplinary communication,and jointly promote research and development in this field.
		                        		
		                        		
		                        		
		                        	
2.Impact of ultrasound-guided thoracic paravertebral nerve block combined with general anesthesia in patients undergoing thoracoscopic surgery and its potential mechanisms
Xiaomeng ZHU ; Sa FAN ; Lei KANG ; Yilan ZHANG ; Chao YUAN ; Fei HUANG
Journal of Clinical Medicine in Practice 2024;28(14):44-48
		                        		
		                        			
		                        			Objective To investigate the effects and potential mechanisms of ultrasound-guided thoracic paravertebral block (TPVB) combined with general anesthesia in patients undergoing thoracoscopic surgery. Methods A total of 122 patients undergoing thoracoscopic surgery were selected and randomly divided into control group and tudy group, with 61 patients in each group.The control group received general anesthesia, while the study group received ultrasound-guided TPVB combined with general anesthesia.Clinical data and perioperative indicators were recorded and compared between the two groups.Mean arterial pressure (MAP), heart rate (HR), Visual Analogue Scale (VAS) scores before surgery, 24 hours and 72 hours after surgery, and inflammatory factors[interleukin-6(IL-6), interleukin-10(IL-10), tumor necrosis factor-α(TNF-α)], oxidative stress indicators[malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px)]levels before surgery and 72 hours after surgery were compared between the two groups.Postoperative adverse reactions were recorded.Real-time fluorescence quantitative polymerase chain reaction was used to detect the expression of key molecules mRNA in the Nrf2/Keap1/ARE pathway in the peripheral blood of patients in the two groups. Results There were no statistically significant differences in operative time and intraoperative blood loss between the two groups (
		                        		
		                        	
3.Analysis of a child with developmental disorder and epilepsy due to a homozygous variant of SLC25A12 gene
Shitao WEI ; Xiaoli HUANG ; Luoxiao QIN ; Mo QIN ; Yilan ZHOU ; Bin YU ; Dejian YUAN ; Rongsong YI ; Yang TIAN
Chinese Journal of Medical Genetics 2024;41(7):830-834
		                        		
		                        			
		                        			Objective:To explore the genetic basis for a child featuring global developmental delay and epilepsy.Methods:A child who had presented at Guangzhou Women and Children′s Medical Center Liuzhou Hospital on February 19, 2023 was selected as the study subject. Clinical data of the child was collected. The child was subjected to whole exome sequencing, and candidate variant was validated by Sanger sequencing and bioinformatic analysis.Results:The child, an 8-month-old girl, had manifested with global developmental delay, epilepsy, and hyperlactacidemia. Cranial MRI revealed diverse hypomyelinating leukodystrophies. Electroencephalogram showed slow background activities. Genetic testing revealed that she has harbored a homozygous variant of the SLC25A12 gene, namely c. 115T>G (p.Phe39Val), for which both of her parents were heterozygous carriers. Based on the guidelines from the American College of Medical Genetics and Genomics, the variant was predicted to be of uncertain significance (PM2_Supporting+ PM3_Supporting+ PP3_Moderate+ PP4_Moderate). I-Mutant v3.0 software predicted that the variant may affect the stability of protein product. Conclusion:The homozygous c. 115T>G (p.Phe39Val) variant of the SLC25A12 gene probably underlay the pathogenesis of the disease in this child.
		                        		
		                        		
		                        		
		                        	
4.Predictors for Failed Removal of Nasogastric Tube in Patients With Brain Insult
Shih-Ting HUANG ; Tyng-Guey WANG ; Mei-Chih PENG ; Wan-Ming CHEN ; An-Tzu JAO ; Fuk Tan TANG ; Yu-Ting HSIEH ; Chun Sheng HO ; Shu-Ming YEH
Annals of Rehabilitation Medicine 2024;48(3):220-227
		                        		
		                        			 Objective:
		                        			To construct a prognostic model for unsuccessful removal of nasogastric tube (NGT) was the aim of our study. 
		                        		
		                        			Methods:
		                        			This study examined patients with swallowing disorders receiving NGT feeding due to stroke or traumatic brain injury in a regional hospital. Clinical data was collected, such as age, sex, body mass index (BMI), level of activities of daily living (ADLs) dependence. Additionally, gather information regarding the enhancement in Functional Oral Intake Scale (FOIS) levels and the increase in food types according to the International Dysphagia Diet Standardization Initiative (IDDSI) after one month of swallowing training. A stepwise logistic regression analysis model was employed to predict NGT removal failure using these parameters. 
		                        		
		                        			Results:
		                        			Out of 203 patients, 53 patients (26.1%) had experienced a failed removal of NGT after six months of follow-up. The strongest predictors for failed removal were age over 60 years, underweight BMI, total dependence in ADLs, and ischemic stroke. The admission prediction model categorized patients into high, moderate, and low-risk groups for removal failure. The failure rate of NGT removal was high not only in the high-risk group but also in the moderate-risk groups when there was no improvement in FOIS levels and IDDSI food types. 
		                        		
		                        			Conclusion
		                        			Our predictive model categorizes patients with brain insults into risk groups for swallowing disorders, enabling advanced interventions such as percutaneous endoscopic gastrostomy for high-risk patients struggling with NGT removal, while follow-up assessments using FOIS and IDDSI aid in guiding rehabilitation decisions for those at moderate risk. 
		                        		
		                        		
		                        		
		                        	
5.Experience in Professional Resilience for Nurses Caring for Patients with COVID-19: A Qualitative Descriptive Study
Pai-En CHIU ; Shu-Chuan A. LIN ; Ya-Ping LI ; Chiao-Hsin HUANG ; Ying-Mei SHU ; Chi-Wen CHEN
Asian Nursing Research 2024;18(1):28-35
		                        		
		                        			 Purpose:
		                        			During the COVID-19 pandemic, nurses have faced many professional and ethical dilemmas and challenges along with bearing physical, mental, and emotional stress resulting from worrying about themselves or their family being infected and stigmatized. This stress can potentially lead to burnout and resignation. Professional resilience is crucial for nurses to cope with these adverse situations. This study aimed to investigate the process by which nurses adapt, change, and overcome challenges during the COVID-19 pandemic and ultimately demonstrate professional resilience. 
		                        		
		                        			Methods:
		                        			Descriptive phenomenology was applied. Semi-structured interviews were conducted with 11 nurses working in COVID-19 wards and intensive care units to collect data. Giorgi's phenomenological analysis method was employed. 
		                        		
		                        			Results:
		                        			Based on the interview responses, four major themes were identified: 1) balancing patient care, self-protection, and passing on experience; 2) providing timely pandemic team resources and social support; 3) nurses' perseverance amid social discourse and constrained lives; and 4) selfless dedication shaping nursing's pinnacle experiences. 
		                        		
		                        			Conclusions
		                        			In the face of a sudden pandemic, frontline nurses play a critical role in maintaining medical capacity. Consequently, they must balance their families, lives, and work while adapting to the impact of the pandemic and changing practices and procedures based on the development of the pandemic and policy demands. The study findings provide insights into the challenges and emotional experiences encountered by nurses during a sudden pandemic outbreak and can serve as a reference for developing strategies to help nurses overcome these challenges and enhance their professional resilience. 
		                        		
		                        		
		                        		
		                        	
6.Immune response after vaccination using inactivated vaccine for coronavirus disease 2019.
Ya SUN ; Haonan KANG ; Yilan ZHAO ; Kai CUI ; Xuan WU ; Shaohui HUANG ; Chaofan LIANG ; Wenqiang WANG ; Huixia CAO ; Xiaoju ZHANG ; Fengmin SHAO
Chinese Medical Journal 2023;136(12):1497-1499
7.Correlation analysis between vitamin A, D and E levels with the altitude, seasonal variation and other factors in children with 0-6 years old in Tibetan Plateau of Ganzi Prefecture
Ping HUANG ; Xinmei LIN ; Quansheng WANG ; Gang KE ; Zhengrong WEI ; Duping GUO ; Xueguo BA ; Yongxiao YUAN ; Qun WANG ; Hongyan DING ; Maoyun HE ; Ligui XIAN ; Liping ZHANG ; Yufei WANG ; Lianhui YU ; Kehong KUANG ; Qingping LUO ; Zhu CHEN ; Hongmei LI ; Jing LUO ; Yilan XU
Chinese Journal of Applied Clinical Pediatrics 2021;36(22):1736-1741
		                        		
		                        			
		                        			Objective:To detect serum levels of vitamin A (Vit A), vitamin D(Vit D)25-hydroxy vitamin D[25-(OH)D] and vitamin E(Vit E) in children aged 0-6 years in Tibetan Plateau of Garzi Prefecture, thus providing references for physical examinations and prevention of 4 key diseases (rickets, malnutrition anemia, pneumonia and diarrhea) in children in plateau areas by relevant government departments.Methods:A total of 2 122 children who participated in physical examination in 12 townships of Xiangcheng County and 14 townships of Daocheng County, Garzi Tibetan Autonomous Prefecture, Sichuan Province from April 2017 to April 2019 with 0-6 years old were recruited for surveying physical measurements and collection of venous blood.Serum Vit A and Vit E levels were detected by high performance liquid chromatography.Serum levels of 25-(OH)D were detected by high performance liquid chromatography tandem mass spectrometry.The relationship between Vit A, Vit E and 25-(OH)D levels with the gender, age, seasonal change and altitude was analyzed.Results:The serum Vit A level, subclinical Vit A deficiency rate and marginal vitamin A deficiency rate were(1.05±0.27) μmol/L, 8.15%(173/2 122 cases) and 45.99%(976/2 122 cases), respectively in 2 122 children with 0-6 years old.There were significant differences in the serum Vit A level, the subclinical Vit A deficiency rate and the marginal vitamin A deficiency rate in children with different ages, seasons and altitudes (all P<0.05). The serum level of 25-(OH)D and 25-(OH)D deficiency rate insufficient rate were (24.65±6.45) ng/L, 6.03%(128/2 122 cases) and 16.59%(352/2 122 cases), respectively.There were significant differences in the serum level of 25-(OH)D, 25-(OH)D deficiency rate and 25-(OH)D insufficient rate in children with different ages and seasons (all P<0.05). The mean serum Vit E level, Vit E deficiency rate and Vit E insufficient rate were (7.81±1.74) mg/L, 2.78%(59/2 122 cases) and 29.59%(628/2 122 cases), respectively.There were significant differences in serum Vit E level, Vit E deficiency rate and Vit E insufficient rate in children with different ages and seasons (all P<0.05). The mean serum levels of Vit A and Vit D remained the lowest before the age of 1 year, and their deficiencies at this age were the most significant.The mean serum level of Vit E remained the lowest in >1-2 years old, and its deficiency and insufficient at this age were the most significant.Vit A, D and E levels were significantly affected by seasonal changes, which were significantly higher in the summer than in the spring, autumn and winter.In addition, Vit A and 25-(OH)D were significantly affected by the altitude, which were the lowest above 4 km altitude. Conclusions:The overall serum levels of Vit A, 25-(OH) D and E in children with 0-6 years old in Tibetan Plateau areas of Ganzi Prefecture are lower than those in plain areas.Vit A, 25-(OH) D and Vit E levels significantly differed in the age, season and altitude, which are related to the lack of local resources, insufficient maternal nutrition during pregnancy and insufficient intake after birth, as well as temperature and light caused by changes in local seasons and altitude.Therefore, it is necessary to make reasonable supplements during pregnancy to prevent vitamin deficiency.
		                        		
		                        		
		                        		
		                        	
8.Application value of dual-source CT urography with stellar photon detectors in the diagnosis of gout
Shouqi MO ; Yilan LI ; Baijie XU ; Xiaoqian XUE ; Weipeng HUANG ; Qiongyu YUAN ; Chaopeng WAN ; Zhenshan WANG
Chinese Journal of Primary Medicine and Pharmacy 2021;28(6):855-859
		                        		
		                        			
		                        			Objective:To investigate the application value of dual-source CT urography with stellar photon detectors in the diagnosis of gout.Methods:Forty patients who were diagnosed with gout according to American College of Rheumatology Guideline for the Diagnosis of Gout and received treatment between April 2018 and May 2020 were included in the observation group. Forty patients who were concurrently diagnosed with osteoarthritis and received treatment in the same hospital were included in the control group. All patients underwent dual-source CT urography with stellar photon detectors and corresponding biochemical index detection. Blood levels of uric acid, urea nitrogen, creatinine, total cholesterol, and triglyceride were compared between the observation and control groups.Results:Blood levels of uric acid, creatinine, urea nitrogen, total cholesterol, and triglyceride in the observation group were (519.38 ± 97.91) μmol/L, (110.21 ± 18.29) μmol/L, (12.21 ± 3.29) mmol/L, (6.49 ± 1.22) mmol/L, (3.45 ± 1.89) mmol/L, respectively, which were significantly higher than those in the control group (310.45 ± 61.40) μmol/L, (86.22 ± 13.12) μmol/L, (6.82 ± 1.75) mmol/L, (4.75 ± 0.56) mmol/L, (1.98 ± 0.85) mmol/L, respectively ( t = 11.43, 6.741, 9.148, 8.198, 4.486, all P < 0.05). Dual-source CT urography with stellar photon detectors revealed that urate crystals (color coded as green) were detected in 3 and 36 patients from the control and observation groups, respectively, with the detection rate of 7.5% (3/40) and 90% (36/40), respectively. There was significant difference in urate crystal detection rate between the observation and control groups ( χ2 = 24.993, P < 0.05). In the control group, no obvious destruction of bone, tendon and ligament were observed, urate deposition, total volume of (1.023 ± 0.83) cm 3, was found in feet and knee joint of a small number of patients. In the observation group, there were 30 patients with uric acid crystals and bone destruction in the metatarsophalangeal joint ( n = 6), distal tibia ( n = 7), distal fibula ( n = 3), proximal talus ( n = 4), proximal calcaneus ( n = 6), and wrist joint ( n = 4). There were 20 patients with ligament or tendon damage, involving deltoid ligament ( n = 2), Achilles tendon ( n = 10), and extensor and flexor tendon ( n = 53). Total volume of uric acid crystals was (32.22 ± 5.83) cm 3. The volume of uric acid crystals deposited in the hand, elbow, feet and knee was (8.00 ± 4.92) cm 3, (5.32 ± 2.75) cm 3, (36.00 ± 15.54) cm 3, and (13.31 ± 9.14) cm 3, respectively. Conclusion:Dual-source CT urography with stellar photon detectors has a high sensitivity in the diagnosis of gout, can accurately locate and quantify uric acid crystals and is of high application value in the diagnosis of gout.
		                        		
		                        		
		                        		
		                        	
9.Effects of ultrasound microbubble-mediated G3BP1 transfection on proliferation and migration of human hepatocarcinoma HepG2 Cells
Wenfan HUANG ; Wen ZHOU ; Yilan ZHANG ; Yan HUANG
Chinese Journal of Endocrine Surgery 2021;15(6):622-626
		                        		
		                        			
		                        			Objective:To investigate the effects of ultrasound microbubble-mediated RasGAP SH3-binding protein 1 (G3BP1) transfection on the proliferation and migration of human liver cancer HepG2 cells.Methods:HepG2 cells were treated with ultrasound targeted microbubble destruction (UTMD) technology-mediated si-G3BP1. The expression of G3BP1 in HepG2 cell lines was detected by Western blot, and the silencing efficiency was analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot. HepG2 cell proliferation and migration were analyzed by flow cytometry, methyl thiazolyl tetrazolium (MTT) , EdU staining, colony formation experiment, wound healing experiment, Transwell experiment and Western blot.Results:After silencing G3BP1 in HepG2 cells, its mRNA and protein levels were significantly reduced (1.01±0.03 vs 0.27±0.03, 1.02±0.01 vs 0.33±0.04) ; UTMD-mediated si-G3BP1 could significantly reduce the proliferation rate (31.49±3.09 vs 12.51±1.02) , proliferation activity (1.20±0.13 vs 0.46±0.31) , EdU-positive cell rate (99.23±1.01 vs 36.75±4.03) , colony formation rate (96.45±1.21 vs 32.67±2.62) , scratch healing rate (97.58±1.04 vs 42.33±2.56) , migration rate (94.28±2.33 vs 39.36±2.51) and Ki67, Cyclin D1, Vimentin protein levels, increase E-cadherin protein levels.Conclusion:UTMD-mediated si-G3BP1 can inhibit the proliferation and migration of human liver cancer HepG2 cells.
		                        		
		                        		
		                        		
		                        	
10.Efficacy and Safety of Ubrogepant and Rimegepant in the Treatment of Acute Migraine :A Meta-analysis
Xin LIU ; Xiaoyan ZHONG ; Changjing XU ; Liya FU ; Dongmei TIAN ; Bin YU ; Yilan HUANG
China Pharmacy 2020;31(16):2017-2022
		                        		
		                        			
		                        			OBJECTIVE:To systemat ically evaluate the efficacy and safety of Ubrogepant and Rimegepant in the treatment of acute migraine ,and to provide evidence-based reference for the clinical treatment. METHODS :Retrieved from PubMed ,Embase, Cochrane Library ,CNKI,VIP,Wanfang database and Clinicaltrials. gov ,randomized controlled trials (RCTs) about the Ubrogepant and Rimegepant (trial group )versus placebo (control group )in the treatment of acute migraine were collected during the inception to Jan. 2020. After literature screening and data extraction ,quality assessment was performed using the bias risk assessment tool provided by the Cochrane system evaluator manual 5.1.0. Meta-analysis was performed by using Stata 16.0 software. RESULTS :Eight RCTs with a total of 7 989 patients were included. The results of Meta-analysis showed that the proportion of patients who were free from pain at 2 h postdose in Ubrogepant group [RR =1.65,95%CI(1.38,1.98),P<0.001] and Rimegepant group [RR =1.69,95%CI(1.46,1.95),P<0.001],the proportion of patients who were free from the most bothersome symptom at 2 h postdose in Ubrogepant group [RR =1.35,95% CI(1.20,1.53),P<0.001] and Rimegepant group [RR =1.37,95%CI(1.24,1.51),P<0.001],and other secondary outcome indicators ( i.e. the proportion of patients with pain relief at 2 h postdose ,the proportion of patients with sustained freedom from pain from 2-24 h postdose ,the proportion of patients with sustained pain relief from 2-24 h postdose ,the proportion of patients without photophobia at 2 h postdose ,the proportion of patients without phonophobia at 2 h postdose ,the proportion of patients without nausea at 2 h postdose )were all significantly better than control group (P<0.05). In terms of safety ,there was no statistical significance in the incidence of total ADR between Ubrogepant group and control group [RR =1.04,95%CI(0.87,1.25),P=0.646],but the incidence of total ADR in Rimegepant group were significantly higher than control group [RR =1.23,95% CI(1.01,1.50),P=0.043]. There was no statistical significance in other security indicators (i.e. incidence of nausea ,dizziness,dry mouth ,somnolence,urinary tract infection)in 2 groups(P>0.05). CONCLUSIONS :Ubrogepant and Rimegepant are effective in the treatment of acute migraine. Ubrogepant is safe ,while Rimegepant may increase the incidence of ADR.
		                        		
		                        		
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail